Uniplan Investment Counsel, Inc.

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1520710 MILWAUKEE, WI

Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,212,304

+$1,938,841 QoQ

Shares Held

116,362

+69.3% QoQ

Ownership

0.357%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

#45

of 279 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Uniplan Investment Counsel, Inc. holds $6,293,960 across 3 Drug Manufacturers - Specialty & Generic names. COLL ranks #1 (66.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	COLL	Collegium Pharmaceutical, Inc This page	116,362	$4,212,304
2	SIGA	Siga Technologies Inc	560,353	$2,039,684
3	ALKS	Alkermes plc.	801	$41,972

All Filings in COLL

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,212,304	116,362	+69.3%	Shares	Sole	2026-08-14
2026-03-31	$2,273,463	68,747	-38.5%	Shares	Sole	2026-05-15
2025-12-31	$5,173,515	111,739	-0.3%	Shares	Sole	2026-02-17
2025-09-30	$3,919,859	112,028	-14.1%	Shares	Sole	2025-11-14
2025-06-30	$3,856,667	130,425	-8.7%	Shares	Sole	2025-08-14
2025-03-31	$4,262,609	142,801	+0.6%	Shares	Sole	2025-05-15
2024-12-31	$4,068,414	142,004	-1.3%	Shares	Sole	2025-02-14
2024-09-30	$5,559,677	143,884	-1.7%	Shares	Sole	2024-11-14
2024-06-30	$4,713,275	146,375	-0.4%	Shares	Sole	2024-08-14
2024-03-31	$5,703,356	146,918	-0.1%	Shares	Sole	2024-05-15
2023-12-31	$4,527,522	147,093	+43.3%	Shares	Sole	2024-02-14
2023-09-30	$2,293,467	102,616	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.